Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
DeNovix Launches Suite of dsDNA Quantification Assays Improving Sensitivity and Dynamic Range
Monday, October 05, 2015
Twenty-fold increase in sensitivity allows quantification of single cell levels of dsDNA.
Enable Injections Introduces Mobile Monitoring and Larger Volume Capabilities to its Compact-Sized High Volume Wearable Injectors
Monday, October 05, 2015
Enable Injections, the developer and manufacturer of a new wearable injector technology platform that allows patients to comfortably and easily self-administer large volume drugs subcutaneously, has announced two major technology advances.
Illumina Expands World's Largest Genomics Analysis Platform
Saturday, October 03, 2015
BaseSpace® professional and enterprise packages enable labs to drive genomics innovation and accelerate digital computing.
Be a Cut Above with New RNA Tools for CRISPR/Cas9
Thursday, October 01, 2015
IDT webinar describes new and optimized tools for more efficient genome editing.
Illumina Launches TruSight® Tumor OncoPanel
Wednesday, September 30, 2015
Focused panel sets the groundwork for Illumina oncology program.
New Data Published on PointMan™ DNA Enrichment Technology
Tuesday, September 29, 2015
Studies confirm utility of PointMan for molecular analysis of CTCs and circulating DNA in liquid biopsies.
Guide for Optimising ChIP Sequencing Library Preparation
Friday, September 18, 2015
Chromatrap®, a business unit of Porvair Sciences, has produced an informative new guide entitled ‘Top 10 Tips for ChIP-seq Library Preparation'.
SYGNIS Launches SunScript™ One Step Reverse Transcriptase-PCR Kit
Wednesday, September 16, 2015
Product available through SYGNIS global network of distribution partners and SYGNIS online shop.
SYGNIS to Present its Innovative Trueprime™ Technology
Saturday, September 12, 2015
Company will present its product portfolio at the Single Cell Genomics Conference 2015.
Showing Results 71 - 80 of 2662
Poverty Marks a Gene, Predicting Depression
New study of high-risk teens reveals a biological pathway for depression.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,100+ scientific and medical posters
4,500+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!